
|Articles|January 15, 2004
Timolol hemihydrate offers affordable brand-name quality
Author(s)Cheryl Guttman
When a decision is made to prescribe a topical beta-blocker for monotherapy or as an add-on agent, timolol hemihydrate (Betimol, Santen) offers many advantages that may make it an excellent option.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
2
FDA grants IDE approval to EyeYon Medical for its US clinical study of EndoArt
3
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
4
First patient treated in ViaLase’s IDE trial
5















































.png)


